A vaccine candidate for HIV steps into phase III trials, signs emerge that antibiotics impair vaccine performance, and other highlights from clinical trials and laboratory studies.
About Morgana Souza
This author has not written his bio yet.
But we are proud to say that Morgana Souza contributed 214 entries already.
Entries by Morgana Souza
Johnson & Johnson is preparing to test an experimental HIV vaccine in the United States and Europe in a move toward developing the first immunization against the deadly disease after decades of frustration. Read Article
Dr.Barouch spoke to Discover Magazine about a promising candidate for an HIV vaccine raises hopes. Read Article
Scientific investigation into the world’s second man cleared of the AIDS virus is zooming in on a gene and a treatment side-effect, as newly-enthused researchers strive to find a cure for the disease that has killed millions.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit